Trexquant Investment’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-29,405
Closed -$376K 1766
2025
Q1
$376K Sell
29,405
-549
-2% -$8.81K ﹤0.01% 1347
2024
Q4
$528K Sell
29,954
-27,348
-48% -$519K 0.01% 1278
2024
Q3
$1.31M Buy
57,302
+32,557
+132% +$736K 0.02% 957
2024
Q2
$568K Buy
+24,745
New +$763K 0.01% 1207
2022
Q3
Sell
-5,918
Closed -$227K 1697
2022
Q2
$227K Sell
5,918
-280
-5% -$10.1K 0.01% 1285
2022
Q1
$246K Sell
6,198
-101
-2% -$3.95K 0.01% 1106
2021
Q4
$262K Buy
+6,299
New +$274K 0.02% 996

Other funds holding NRC

Trexquant Investment's NRC Position: Q2 2025 in Review

Trexquant Investment sold out of NRC Health Common Stock (NRC) in Q2 2025, closing a stake of 29,405 shares — an estimated $376K sold.

Trexquant Investment first reported a position in NRC in Q4 2021 and held it in 7 quarters. The position peaked at $1.31M in Q3 2024. 126 funds tracked by Wall St. Rank hold NRC as of Q2 2025.

  • Trexquant Investment reported no remaining NRC Health Common Stock position as of Q2 2025 after selling out during the quarter.
  • Trexquant Investment sold 29,405 NRC Health Common Stock shares in Q2 2025, an estimated $376K.
  • Trexquant Investment first reported a position in NRC Health Common Stock in Q4 2021 and held it in 7 quarters.
  • Trexquant Investment's NRC Health Common Stock position peaked at $1.31M in Q3 2024.
  • 126 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2025.

Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.